Acute Pancreatitis Clinical Trial
To quantitatively analyze the T2* values of the head, body, and tail of normal pancreas, and observe the value of GRE T2*-weighted MRI in the diagnosis of acute pancreatitis and the relationship between the T2* value and the severity of AP.
1. We design a prospective study about "Magetic Resonance Imaging Study of Acute
Pancreatitis".
2. We apply for an account and register our study on the clinicalTrials.
3. In patients with acute pancreatitis, imaging is recommended to confirm the clinical
diagnosis, investigate the etiology, and grade the severity of the disease . MR had the
excellent resolution of soft tissue,and it has earned an ever more important role in
the diagnosis of AP. With the continuous development of MR scanning techniques, the
sequence of a multi-echo gradient recalled echo (GRE) T2*-weighted imaging (T2*WI),
which acquires a spin echo signal, T2* relaxation acquires a gradient echo signal, is a
relatively new MRI technique. The sequence of a GRE T2*WI requires high uniformity of
the magnetic field, plus it can provide the T2* value, which can indirectly reflect
changes in tissue biochemical components, thus it can be used for the early diagnosis
quantitative diagnosis of some diseases .
4. This calculation process for T2* value is completed using post-processing software on
the workstation(Advantage workstation 4.4; GE Halthcare) directly after scanning.
5. AP is a process of inflammation diffusion, in which cell edema will lead to hydrogen
proton increase. In the inflammatory exudation process, T2* value will change. So we
conduct our research. In this study, we will observe pancreas in the normal pancreas
and AP, and discuss the relationship between T2* value and that of AP graded by the MR
severity index (MRSI) and Acute Physiology And Chronic Healthy Evaluation II (APACHE
II) scores.
6. However, until now, there is no research on the sequence applied in the patients with
AP.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05410795 -
Establishment and Verification of Pancreatic Volume Formula Based on Imaging
|
||
Recruiting |
NCT04195347 -
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
|
Phase 1/Phase 2 | |
Completed |
NCT04735055 -
Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
|
||
Completed |
NCT02928718 -
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
|
||
Terminated |
NCT02885441 -
Treatment of Acute Pancreatitis With Ketorolac
|
Phase 4 | |
Completed |
NCT02563080 -
Pancreatic Exocrine Insufficiency in Acute Pancreatitis
|
||
Recruiting |
NCT01626911 -
Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis
|
N/A | |
Completed |
NCT01507766 -
The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis
|
Phase 4 | |
Completed |
NCT04901949 -
The Course of Acute Pancreatitis in Patients With Different BMI Groups
|
||
Recruiting |
NCT04814693 -
Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis
|
N/A | |
Completed |
NCT02743364 -
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis
|
Phase 2 | |
Recruiting |
NCT05281458 -
Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections
|
N/A | |
Not yet recruiting |
NCT04990336 -
Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis
|
N/A | |
Not yet recruiting |
NCT03259880 -
Searching the Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals
|
N/A | |
Completed |
NCT02543658 -
Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension
|
Phase 2 | |
Recruiting |
NCT06023771 -
Invasive Intervention of Local Complications of Acute Pancreatitis
|
||
Not yet recruiting |
NCT05501314 -
Remote Home Monitoring Acute Pancreatitis
|
N/A | |
Completed |
NCT02897206 -
Imipenem Prophylaxis in Patients With Acute Pancreatitis
|
Phase 4 | |
Recruiting |
NCT03634787 -
Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
|
||
Active, not recruiting |
NCT04989166 -
Effect of Nano-curcumin Supplementation in Acute Pancreatitis
|
N/A |